Meds A-Z
Doramectin
Detailed information about Doramectin
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
For prevention and treatment of infestations caused by larvae of Cochliomyia hominivorax (myiasis), and prevention of reinfestation for 21 days in cattle.
What it does:
For the treatment and control of the following nematode and arthropod parasites in swine: Gastrointestinal Roundworms Hyostrongylus rubidus - Adults Ascaris suum - Adults, and fourth-stage larvae Oesophagostomum dentatum...
When it's needed:
For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, t...
Call your vet sooner if you notice:
- For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal.
Commonly reported reactions:
- (2 reports)
- (2 reports)
- (2 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Doramectin
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Zoetis Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141616 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141553 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal.
- High: For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 2 | Cat, Dog | 2 | |
| 2 | Cat, Dog | 1 | |
| 2 | Cat, Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 1 |
Species coverage: Dog (21) Cat (11)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Unknown | - | - | |
| Cat | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2024-US-051911
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 28 • Secondary summaries: 0
- FOI Summary o 141-616 Approved September 30, 2025.pdf · FOI
- DECTOMAX®-CA1 · SPL
- FOI Summary oN 141-553 Approved September 9, 2022.pdf · FOI
- VALCOR® · SPL
- FOI Summary oA 200-636 Approved November 20, 2024.pdf · FOI
- DORACIDE™ · SPL
- FOI Summary oA 200-750 Approved May 25, 2023.pdf · FOI
- Doraject™ · SPL
- ucm116701.pdf · FOI
- UCM116711.pdf · FOI
- N141061 _Supp_09_18_1997.pdf · FOI
- N141061 Supp_7_18_1997_.pdf · FOI
- UCM489435.pdf · FOI
- 141-061 · EA
- 141-061 · FONSI
- 141-061 · EA
- 141-061 · FONSI
- Dectomax® Injectable Solution for Cattle and Swine · SPL
- FOI Summary oA 200-738 Approved January 11, 2023.pdf · FOI
- DectoGard™ · SPL
- ucm117105.pdf · FOI
- ucm117102.pdf · FOI
- ucm117101.pdf · FOI
- ucm117099.pdf · FOI
- N141095 Orig_9_16_1997.pdf · FOI
- 141-095 · EA
- 141-095 · FONSI
- Dectomax® Pour-on Solution for Cattle · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17486 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17826/DECTOMAX%C2%AE-CA1 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/12914 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/12990/VALCOR%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/16286 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/16625/DORACIDE%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14057 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/14293/Doraject%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/594 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/593 · document · FOI
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:02 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:20 AM UTC
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 20076-0406-2 | 20076 | - | |
| 20076-2014-9 | 20076 | - | |
| 30798-315-19 | 30798 | - | |
| 30798-545-10 | 30798 | - | |
| 30798-545-13 | 30798 | - | |
| 30798-545-17 | 30798 | - | |
| 51072-107-00 | 51072 | - | |
| 51072-107-01 | 51072 | - | |
| 51072-107-02 | 51072 | - | |
| 54771-1685-1 | 54771 | - | |
| 54771-1685-2 | 54771 | - | |
| 54771-1685-3 | 54771 | - | |
| 54771-2718-2 | 54771 | - | |
| 54771-2718-3 | 54771 | - | |
| 54771-2718-4 | 54771 | - | |
| 54771-5438-1 | 54771 | - | |
| 54771-5438-2 | 54771 | - | |
| 54771-5438-3 | 54771 | - | |
| 61133-4004-2 | 61133 | - | |
| 61133-4004-3 | 61133 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FOI Summary o 141-616 Approved September 30, 2025.pdf
• FOI summary • Official
• Oct. 30, 2025
FDA FOI summary for application 141616
-
FOI Summary oN 141-553 Approved September 9, 2022.pdf
• FOI summary • Official
• March 4, 2025
FDA FOI summary for application 141553
-
FOI Summary oA 200-636 Approved November 20, 2024.pdf
• FOI summary • Official
• Dec. 2, 2024
FDA FOI summary for application 200636
-
FOI Summary oA 200-750 Approved May 25, 2023.pdf
• FOI summary • Official
• June 1, 2023
FDA FOI summary for application 200750
-
UCM489435.pdf
• FOI summary • Official
• April 17, 2023
FDA FOI summary for application 141061
-
N141061 Supp_7_18_1997_.pdf
• FOI summary • Official
• April 17, 2023
FDA FOI summary for application 141061
-
N141061 _Supp_09_18_1997.pdf
• FOI summary • Official
• April 17, 2023
FDA FOI summary for application 141061
-
UCM116711.pdf
• FOI summary • Official
• April 17, 2023
FDA FOI summary for application 141061
-
ucm116701.pdf
• FOI summary • Official
• April 17, 2023
FDA FOI summary for application 141061
-
FOI Summary oA 200-738 Approved January 11, 2023.pdf
• FOI summary • Official
• Feb. 1, 2023
FDA FOI summary for application 200738
-
N141095 Orig_9_16_1997.pdf
• FOI summary • Official
• July 9, 2018
FDA FOI summary for application 141095
-
ucm117099.pdf
• FOI summary • Official
• July 9, 2018
FDA FOI summary for application 141095
-
ucm117101.pdf
• FOI summary • Official
• July 9, 2018
FDA FOI summary for application 141095
-
ucm117102.pdf
• FOI summary • Official
• July 9, 2018
FDA FOI summary for application 141095
-
ucm117105.pdf
• FOI summary • Official
• July 9, 2018
FDA FOI summary for application 141095
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Accidental exposure, Blindness, Death, Labeled drug-species interaction, Lethargy (see also Central nervous system depression… (Official, 2026-02-12)
- usage: For the treatment and control of the following nematode and arthropod parasites in swine: Gastrointestinal Roundworms Hyostrongylus rubidus - Adults Ascaris su… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
DECTOMAX®-CA1
OTC
Doramectin
Injectable Solution
• Injection
|
Zoetis Inc. | C 141-616 | Approved | Oct 30, 2025 |
|
VALCOR®
RX
Doramectin Levamisole
Injectable Solution
• Subcutaneous
|
Zoetis Inc. | NADA 141-553 | Approved | Mar 4, 2025 |
|
DORACIDE™
OTC
Doramectin
Topical Solution
• Topical
|
Bimeda Animal Health Limited | ANADA 200-636 | Approved | Dec 2, 2024 |
|
Doraject™
OTC
Doramectin
Injectable Solution
• Subcutaneous, Intramuscular
|
Cronus Pharma Specialities India Private Ltd. | ANADA 200-750 | Approved | Jun 1, 2023 |
|
Dectomax® Injectable Solution for Cattle and Swine
OTC
Doramectin
Liquid (Solution)
• Intramuscular, Subcutaneous
|
Zoetis Inc. | NADA 141-061 | Approved | Apr 17, 2023 |
|
DectoGard™
OTC
Doramectin
Topical Solution
• Topical
|
Aurora Pharmaceutical, Inc. | ANADA 200-738 | Approved | Feb 1, 2023 |
|
Dectomax® Pour-on Solution for Cattle
OTC
Doramectin
Liquid (Solution)
• Topical
|
Zoetis Inc. | NADA 141-095 | Approved | Jul 9, 2018 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
For prevention and treatment of infestations caused by larvae of Cochliomyia hominivorax (myiasis), and prevention of reinfestation for 21 days in cattle.
1 mL (10 mg doramectin) per 110 lb of body weight (200 mcg/kg) administered by subcutaneous or intramuscular injection in the neck region.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of gastrointestinal roundworms (adults and fourth stage larvae) - Ostertagia ostertagi (including inhibited larvae), O. lyrata, Haemonchus placei, Trichostrongylus axei, T. colubriformis, T. longispicularis*, Cooperia oncophora, C. pectinata*, C. punctata, C. surnabada, Bunostomum phlebotomum*, Strongyloides papillosus*, Oesophagostomum radiatum, Trichuris spp.*, and Nematodirus helvetianus*; lungworms (adults and fourth stage larvae) - Dictyocaulus viviparus; eyeworms (adults) - Thelazia spp.; grubs (parasitic stages) - Hypoderma bovis and H. lineatum; sucking lice - Haematopinus eurysternus, Linognathus vituli, and Solenopotes capillatus; mange mites - Psoroptes bovis and Sarcoptes scabiei.
*adults only
Inject subcutaneously as a single dose at a dosage of 0.2 mg doramectin and 6 mg of levamisole hydrochloride per kg of body weight.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
DORACIDE™ Pour-On solution is indicated for the treatment and control of the following species of gastrointestinal roundworms, lungworms, eyeworms, grubs, biting and sucking lice, horn flies, and mange mites in cattle.
Gastrointestinal roundworms
Ostertagia ostertagi (adults and L4, including inhibited larvae)
O. lyrata (adults)
Haemonchus placei (adults and L4)
Trichostrongylus axei (adults and L4)
T. colubriformis (adults and L4)
Cooperia oncophora (adults1 and L4)
C. pectinata (adults)
C. punctata (adults and L4)
C. surnabada (adults)
Bunostomum phlebotomum (adults)
Oesophagostomum radiatum (adults and L4)
Trichuris spp. (adults)
1Efficacy below 90% was observed against adult C. oncophora in some clinical studies.
Lungworms (adults and fourth stage larvae)
Dictyocaulus viviparus
Eyeworms
Thelazia gulosa (adults)
T. skrjabini (adults)
Lice
Biting Lice
Bovicola (Damalinia) bovis
Sucking Lice
Haematopinus eurysternus
Linognathus vituli
Solenopotes capillatus
Grubs
Hypoderma bovis
H. lineatum
Horn Flies
Haematobia irritans
Mange Mites
Chorioptes bovis
Sarcoptes scabiei
Doramectin topical solution has been proved to effectively control infections and to protect cattle from reinfection with Cooperia oncophora, Dictyocaulus viviparus, Ostertagia ostertagi, and Oesophagostomum radiatum for 28 days; and Cooperia punctata and Haemonchus placei for 35 days after treatment.
Doramectin topical solution has been proved to effectively control infestations and to protect cattle from reinfestation with Bovicola (Damalinia) bovis for 77 days and Linognathus vituli for 42 days after treatment.
Management Considerations for Horn Flies
DORACIDE™ Pour-On solution provides 7 days of persistent activity against horn flies. The product should be used as part of an integrated control program and be combined with other methods for extended horn fly control.
Administer topically at a dosage of 500 mcg doramectin per kg (227 mcg/lb) of body weight. Each mL contains 5 mg of doramectin, sufficient to treat 22 lb (10 kg) of body weight.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of the following harmful species of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice, and mange mites.
Gastrointestinal Roundworms (adults and fourth stage larvae)
Ostertagia ostertagi (including inhibited larvae)
O. lyrata
Haemonchus placei
Trichostrongylus axei
T. colubriformis
T. longispicularis1
Cooperia oncophora
C. pectinata1
C. punctata
C. surnabada (syn. mcmasteri)
Bunostomum phlebotomum1
Strongyloides papillosus1
Oesophagostomum radiatum
Trichuris spp.1
Lungworms (adults and fourth stage larvae)
Dictyocaulus viviparus
Eyeworms (adults)
Thelazia spp.
Grubs (parasitic stages)
Hypoderma bovis
H. lineatum
Sucking lice
Haematopinus eurysternus
Linognathus vituli
Solenopotes capillatus
Mange Mites
Psoroptes bovis
Sarcoptes scabiei
1adults
It has been proved to effectively control infections and to protect cattle from reinfection with Cooperia oncophora and Haemonchus placei for 14 days, Ostertagia ostertagi for 21 days, and C. punctata, Oesophagostomum radiatum, and Dictyocaulus viviparus for 28 days after treatment.
1 mL (10 mg doramectin) per 110 lb of body weight (200 mcg/kg) administered by subcutaneous (SC) or intramuscular (IM) injection in the neck region.
For the treatment and control of the following species of gastrointestinal roundworms, kidney worms, sucking lice, and mange mites.
Gastrointestinal Roundworms
(adults and fourth stage larvae)
Ascaris suum
Oesophagostomum dentatum
Oesophagostomum quadrispinulatum1
Strongyloides ransomi1
Hyostrongylus rubidus1
1adults
Lungworms (adults)
Metastrongylus spp.
Kidney worms (adults)
Stephanurus dentatus
Mange Mites (adults and immature stages)
Sarcoptes scabiei var. suis
Sucking Lice (adults and immature stages)
Haematopinus suis
1 mL (10 mg doramectin) per 75 lb of body weight (300 mcg/kg) administered by IM injection only.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of the following species of gastrointestinal roundworms, lungworms, eyeworms, grubs, biting and sucking lice, horn flies, and mange mites in cattle.
Gastrointestinal roundworms
- Ostertagia ostertagi (adults and L4, including inhibited larvae)
- O. lyrata (adults)
- Haemonchus placei (adults and L4)
- Trichostrongylus axei (adults and L4)
- T. colubriformis (adults and L4)
- Cooperia oncophora (adults1 and L4)
- C. pectinata (adults)
- C. punctata (adults and L4)
- C. surnabada (adults)
- Bunostomum phlebotomum (adults)
- Oesophagostomum radiatum (adults and L4)
- Trichuris spp. (adults)
1Efficacy below 90% was observed against adult C. oncophora in some clinical studies.
Lungworms (adults and fourth stage larvae)
Dictyocaulus viviparus
Eyeworms
Thelazia gulosa (adults)
T. skrjabini (adults)
Lice
Biting Lice
Bovicola (Damalinia) bovis
Sucking Lice
Haematopinus eurysternus
Linognathus vituli
Solenopotes capillatus
Grubs
Hypoderma bovis
H. lineatum
Horn Flies
Haematobia irritans
Mange Mites
Chorioptes bovis
Sarcoptes scabiei
Doramectin topical solution has been proved to effectively control infections and to protect cattle from reinfection with Cooperia oncophora, Dictyocaulus viviparus, Ostertagia ostertagi, and Oesophagostomum radiatum for 28 days; and Cooperia punctata and Haemonchus placei for 35 days after treatment.
Doramectin topical solution has been proved to effectively control infestations and to protect cattle from reinfestation with Bovicola (Damalinia) bovis for 77 days and Linognathus vituli for 42 days after treatment.
Administer topically at a dosage of 500 mcg doramectin per kg (227 mcg/lb) of body weight. Each mL contains 5 mg of doramectin, sufficient to treat 22 lb (10 kg) of body weight.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
Summary
For prevention and treatment of infestations caused by larvae of Cochliomyia hominivorax (myiasis), and prevention of reinfestation for 21 days in cattle.
- DECTOMAX®-CA1 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the treatment and control of gastrointestinal roundworms (adults and fourth stage larvae) - Ostertagia ostertagi (including inhibited larvae), O. lyrata, Haemonchus placei, Trichostrongylus axei, T. colubriformis, T. longispicularis*, Cooperia oncophora, C. pectinata*, C. punctata, C. surnabada, Bunostomum phlebotomum*, Strongyloides papillosus*, Oesophagostomum radiatum, Trichuris spp.*, and Nematodirus helvetianus*; lungworms (adults and fourth stage larvae) - Dictyocaulus viviparus; eyeworms (adults) - Thelazia spp.; grubs (parasitic stages) - Hypoderma bovis and H. lineatum; sucking lice - Haematopinus eurysternus, Linognathus vituli, and Solenopotes capillatus; mange mites - Psoroptes bovis and Sarcoptes scabiei.
*adults only
- VALCOR® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, biting and sucking lice, horn flies, and mange mites in cattle.
- DORACIDE™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
Cattle: For treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice, and mange mites. It has been proved to effectively control infections and to protect cattle from reinfection with Cooperia oncophora and Haemonchus placei for 14 days, Ostertagia ostertagi for 21 days, and C. punctata, Oesophagostomum radiatum, and Dictyocaulus viviparus for 28 days after treatment.
Swine: For treatment and control of gastrointestinal roundworms, lungworms, kidney worms, sucking lice, and mange mites.
- Doraject™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm116701.pdf
Summary
New indication for persistent control of nematodes in cattle adding protection against Haemonchus placei for 14 days after treatment. -
FOI UCM116711.pdf
Summary
Provides for the addition of persistent efficacy to protect cattle from reinfection with Cooperia oncophora for 14 days and Oesophagostomum radiatum for 28 days after treatment. -
Summary
Adds swine to the previously approved NADA.
-
Summary
New claims for persistent control of gastrointestinal roundworms and lungworms in cattle.
-
FOI UCM489435.pdf
Summary
For the treatment and control of certain nematode and arthropod parasites in cattle. -
EA 141-061
-
FONSI 141-061
-
EA 141-061
-
FONSI 141-061
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, biting and sucking lice, horn flies, and mange mites in cattle
- DectoGard™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm117105.pdf
Summary
This supplement allows the following additional persistent effect indications. DECTOMAX Pour-On solution has been proved to effectively control infestations and to protect cattle from reinfestation with Bovicola ( Damalinia) bovis for 77 days and Linognathus vituli for 42 days after treatment. -
FOI ucm117102.pdf
Summary
For treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, lice, mange mites and horn flies. To protect cattle from reinfection with Cooperia oncophora, D. viviparus, Ostertagia ostertagi, and O.radiatum for 28 days; and with C. punctata, and Haemonchus placei for 35 days after treatment. -
FOI ucm117101.pdf
Summary
Provides for addition of a therapeutic claim for Trichostrongylus axei L4 and a persistency claim of 35 days for Haemonchus placei. -
FOI ucm117099.pdf
Summary
Adds to labeling a new indication for treatment and control of horn fly, Haematobia irritans -
Summary
To control infections and to protect cattle from re-infection with Cooperia oncophora and Dictyocaulus viviparus for 21 days, and Ostertagia ostertagi, Cooperia puctata, and oesophagostomum radiatum for 28 days after treatment.
-
EA 141-095
-
FONSI 141-095
FDA page: Open in Animal Drugs @ FDA
Usage
For the treatment and control of the following nematode and arthropod parasites in swine: Gastrointestinal Roundworms Hyostrongylus rubidus - Adults Ascaris suum - Adults, and fourth-stage larvae Oesophagostomum dentatum - Adults, and fourth-stage larvae Oesophagostomum quadrispinulatum - Adults Strongyloides ransomi - Adults Lungworms Metastrongylus spp. - Adults Kidneyworms Stephanurus dentatus - Adults Sucking Lice Haematopinus suis - Adults and Immature stages Mange Mites Sarcoptes scabiei var. suis - Adults and Immature stages For the treatment and control of the following in cattle: Gastrointestinal roundworms : Ostertagia ostertagi (Adults and fourth-stage larvae) Ostertagia ostertagi (Inhibited fourth-stage larvae) Ostertagia lyrata (Adults and fourth-stage larvae) Haemonchus placei (Adults and fourth-stage larvae) Trichostrongylus axei (Adults and fourth-stage larvae) Trichostrongylus colubriformis (Adults and fourth-stage larvae) Trichostrongylus longispicularis (Adults) Cooperia oncophora (Adults and fourth-stage larvae) Cooperia punctata (Adults and fourth-stage larvae) Cooperia pectinata (Adults) Cooperia surnabada ( syn. mcmasteri ) (Adults and fourth-stage larvae) Bunostomum phlebotomum (Adults) Strongyloides papillosus (Adults) Oesophagostomum radiatum (Adults and fourth-stage larvae) Trichuris spp. (Adults) Lungworms Dictyocaulus viviparus (Adults and fourth-stage larvae) Eyeworms Thelazia spp. (Adults) Grubs Hypoderma bovis Hypoderma lineatum Lice Haematopinus eurysternus Linognathus vituli Solenopotes capillatus Mange mites Psoroptes bovis Sarcoptes scabiei Dectomax injectable solution has been proved to effectively control infections and to protect cattle from reinfection with Cooperia oncophora and Haemonchus placei for 14 days; Ostertagia ostertagi for 21 days; and Cooperia punctata , Oesophagostomum radiatum , and Dictyocaulus viviparus for 28 days after treatment. For treatment and control of gastrointestinal roundworms: Ostertagia ostertagi (adults and fourth- stage larvae), O. ostertagi (inhibited fourth-stage larvae), O. lyrata (adults), Haemonchus placei (adults and fourth-stage larvae), Trichostrongylus axei (adults and fourth-stage larvae), T. colubriformis (adults and fourth-stage larvae), Cooperia oncophora (adults and fourth-stage larvae), C. punctate (adults and fourth-stage larvae), C. pectinate (adults), C. surnabada (adults), Bunostomum phlebotomum (adults), Oesophagostomum radiatum (adults and fourth-stage larvae), Trichuris spp. (adults); lungworms: Dictyocaulus viviparous (adults and fourth-stage larvae); eyeworms: Thelazia gulosa (adults), T. skrjabini (adults); grubs: Hypoderma bovis and H. lineatum ; sucking lice: Linognathus vituli , Haematopinus eurysternus , and Solenopotes capillatus ; biting lice: Damalinia bovis ; mange mites: Chorioptes bovis and Sarcoptes scabiei ; horn flies: Haematobia irritans ; and to control infections and to protect from reinfection with C. oncophora , D. viviparous , O. os
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. For use in Cattle and Swine only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 20 and Cat 8 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Mixed (Dog), Male, 9 year, 12.655 kilogram • Drug: MSK, Suspension, Oral • Reactions: Lack of efficacy (endoparasite) - heartworm, Intentional misuse • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-056100
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 9.00 Year
- Weight: 12.655 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Suspension
Dog, Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog), Female, 2 year, 17.236 kilogram • Drug: MSK, Suspension, Oral • Reactions: Accidental exposure, Panting, Vomiting, Mydriasis, Disorientation… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2024-US-051911
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 2.00 Year
- Weight: 17.236 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Suspension
Dog, Boxer (German Boxer), Male, 8 year, 16.783 kilogram • Drug: MSK, Suspension, Oral • Reactions: Blindness, Dilated pupils, Increased sensitivity to light, Shaking, Unable to stand • Outcome: Ongoing
- Report ID: USA-USFDACVM-2024-US-037925
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 8.00 Year
- Weight: 16.783 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Suspension
Dog, Dog (unknown), Unknown • Drug: MSK, Suspension, Oral • Reactions: General illness, Inappropriate packaging or design, Vials, Damaged, Accidental exposure, Incorrect route of drug administration… • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2024-US-014501
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Unknown
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Suspension
Dog, Dog (unknown), Unknown • Drug: MSK, Suspension, Unknown • Reactions: Lack of efficacy (endoparasite) - hookworm, Administration error NOS • Outcome: Ongoing
- Report ID: USA-USFDACVM-2023-US-048157
- Serious AE: No
- Treated For AE: No
- Sex: Unknown
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Suspension
Cat, Cat (other), Female, 10 year, 4.536 kilogram • Drug: MSK, Suspension, Oral • Reactions: Tremors, Hyperaesthesia, Accidental exposure • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2023-US-007327
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 10.00 Year
- Weight: 4.536 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Suspension
Cat, Cat (other), Unknown • Drug: MSK, Solution, Oral • Reactions: Seizure NOS, Accidental exposure • Outcome: Ongoing
- Report ID: USA-USFDACVM-2022-US-052816
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Unknown
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Solution
Cat, Cat (other), Male, 2 year • Drug: MSK, Suspension, Unknown • Reactions: Tiredness (lethargy), Not himself/herself, Breathing difficulty, Accidental exposure • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2021-US-048868
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 2.00 Year
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Suspension
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.